-
We would do the work to create a data analysis engine, a way of monitoring devices, or an operational intelligence system and we would support some planned activity.
FORBES: New Sources for Business Surprises
-
As a result of the positive interim analysis, the FAME II independent Data Safety Monitoring Board (DSMB) has recommended investigators stop patient enrollment in this trial as the DSMB considers it unethical to continue to randomize patients to optimal medical therapy (OMT) alone.
FORBES: New Enrollment in FAME II Halted After Interim Analysis Shows Benefits of FFR
-
He writes the data in the Peto analysis should only have been made available to the committees monitoring the safety of the patients in SHARP and IMPROVE-IT.
FORBES: Magazine Article